Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $20.7900 (1.51%) ($19.9300 - $20.8500) on Mon. Apr. 17, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.56% (three month average) | RSI | 53 | Latest Price | $20.7900(1.51%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.1% a day on average for past five trading days. | Weekly Trend | EDIT declines -3.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(62%) IBB(62%) XBI(60%) IWO(57%) ARKK(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.78% in a week (0% probabilities). VIXM(-13%) TLT(-6%) SHY(-5%) UUP(-4%) IPO(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.78% (StdDev 5.56%) | Hourly BBV | 0 () | Intraday Trend | 1.5% | | | |
|
1 - 5 Day Possible Target | $11.59(-44.25%) | Resistance Level | $21.04 | 5 Day Moving Average | $20.48(1.51%) | 10 Day Moving Average | $20.88(-0.43%) | 20 Day Moving Average | $21.04(-1.19%) | To recent high | -23.8% | To recent low | 21.8% | Market Cap | $1.291b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |